Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kindolor Tosylate in Healthy Adults
NCT06243835Phase 1Terminated
- Sponsor
- Lohocla Research Corporation
- Start
- Apr 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of kindolor in chronic pain (5 arms), sponsored by Lohocla Research Corporation. Primary endpoint: Treatment-Emergent Adverse Events. Started Apr 2024; status: terminated.
02
Drugs
kindolor
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT06243835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06243835.